JP7401156B1 - 子宮、卵管および卵巣における炎症の予防および／または治療剤 - Google Patents

子宮、卵管および卵巣における炎症の予防および／または治療剤 Download PDF

Info

Publication number
JP7401156B1
JP7401156B1 JP2023538945A JP2023538945A JP7401156B1 JP 7401156 B1 JP7401156 B1 JP 7401156B1 JP 2023538945 A JP2023538945 A JP 2023538945A JP 2023538945 A JP2023538945 A JP 2023538945A JP 7401156 B1 JP7401156 B1 JP 7401156B1
Authority
JP
Japan
Prior art keywords
ovaries
uterus
fallopian tubes
inflammation
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023538945A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2024100756A1 (https=
JPWO2024100756A5 (https=
Inventor
真生 萩原
廣繁 三鴨
志達 高橋
健太郎 岡
理 有吉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Miyarisan Pharmaceutical Co Ltd
Original Assignee
Miyarisan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miyarisan Pharmaceutical Co Ltd filed Critical Miyarisan Pharmaceutical Co Ltd
Application granted granted Critical
Publication of JP7401156B1 publication Critical patent/JP7401156B1/ja
Publication of JPWO2024100756A1 publication Critical patent/JPWO2024100756A1/ja
Publication of JPWO2024100756A5 publication Critical patent/JPWO2024100756A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2023538945A 2022-11-08 2022-11-08 子宮、卵管および卵巣における炎症の予防および／または治療剤 Active JP7401156B1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2022/041509 WO2024100756A1 (ja) 2022-11-08 2022-11-08 子宮、卵管および卵巣における炎症の予防および／または治療剤

Publications (3)

Publication Number Publication Date
JP7401156B1 true JP7401156B1 (ja) 2023-12-19
JPWO2024100756A1 JPWO2024100756A1 (https=) 2024-05-16
JPWO2024100756A5 JPWO2024100756A5 (https=) 2024-10-09

Family

ID=89190282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023538945A Active JP7401156B1 (ja) 2022-11-08 2022-11-08 子宮、卵管および卵巣における炎症の予防および／または治療剤

Country Status (2)

Country Link
JP (1) JP7401156B1 (https=)
WO (1) WO2024100756A1 (https=)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007114378A1 (ja) 2006-03-31 2007-10-11 Nippon Paper Chemicals Co., Ltd. 飲食用組成物
JP2020505471A (ja) 2017-01-27 2020-02-20 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイションＴｅｍｐｌｅ Ｕｎｉｖｅｒｓｉｔｙ−Ｏｆ Ｔｈｅ Ｃｏｍｍｏｎｗｅａｌｔｈ Ｓｙｓｔｅｍ Ｏｆ Ｈｉｇｈｅｒ Ｅｄｕｃａｔｉｏｎ 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用
JP2020513554A (ja) 2016-12-07 2020-05-14 プロジェニティ， インコーポレイテッド 胃腸管の検出方法、装置およびシステム
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
JP2021528384A (ja) 2018-06-05 2021-10-21 フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド 代謝障害および非アルコール性脂肪肝疾患の治療のための活性薬剤およびその使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08252088A (ja) * 1995-03-17 1996-10-01 Nippo Kagaku Kk クロストリジウム属細菌の培養方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007114378A1 (ja) 2006-03-31 2007-10-11 Nippon Paper Chemicals Co., Ltd. 飲食用組成物
JP2020513554A (ja) 2016-12-07 2020-05-14 プロジェニティ， インコーポレイテッド 胃腸管の検出方法、装置およびシステム
JP2020505471A (ja) 2017-01-27 2020-02-20 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイションＴｅｍｐｌｅ Ｕｎｉｖｅｒｓｉｔｙ−Ｏｆ Ｔｈｅ Ｃｏｍｍｏｎｗｅａｌｔｈ Ｓｙｓｔｅｍ Ｏｆ Ｈｉｇｈｅｒ Ｅｄｕｃａｔｉｏｎ 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
JP2021528384A (ja) 2018-06-05 2021-10-21 フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド 代謝障害および非アルコール性脂肪肝疾患の治療のための活性薬剤およびその使用方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Animals，2022年10月10日，Vol.12，Article No.2719
Microbiology Spectrum，2022年11月02日，Vol.10, No.6，e0328622

Also Published As

Publication number Publication date
JPWO2024100756A1 (https=) 2024-05-16
WO2024100756A1 (ja) 2024-05-16

Similar Documents

Publication Publication Date Title
EP0667107B1 (en) Bifidobacterium growth promoter
US20220031774A1 (en) Pharmaceutical composition for preventing or treating cancer, comprising weissella cibaria wikim28 as active ingredient
JP7534870B2 (ja) 腸管発達促進用組成物、および腸疾患の予防、治療または症状軽減用組成物
WO2017130859A1 (ja) 神経細胞死抑制剤
CN104011199B (zh) 双歧杆菌增殖促进剂
WO2021235486A1 (ja) 腸管発達促進用組成物、肺機能改善用組成物および免疫機能向上用組成物
WO2018168449A1 (ja) ペプチドグリカン認識タンパク質産生促進用組成物
JPWO2020246583A1 (ja) 組成物
CN108367034A (zh) 面向婴儿的感染防御剂
JPWO2005099725A1 (ja) 炎症性腸疾患予防および／または治療剤
JP4498924B2 (ja) ラクトバシラス・カゼイ亜種カゼイ増殖促進用組成物
JP7401156B1 (ja) 子宮、卵管および卵巣における炎症の予防および／または治療剤
JP6902767B1 (ja) 乳酸菌を含む腸内フローラ改善剤
JP2025098293A (ja) 栄養組成物
JPWO2002080947A1 (ja) 酪酸転化能を有する菌含有組成物及びそれを用いた消化管の乳酸過多及び大腸がんの予防・治療方法
TWI745454B (zh) 抑制腸道內乳桿菌屬乳酸菌減少用之組成物
JP2023513097A (ja) ワイセラ・シバリアｗｉｋｉｍ２８を有効成分として含む癌の予防又は治療用薬学組成物
JP2010280582A (ja) 抗ヘリコバクター剤
JP7067827B1 (ja) インターフェロン産生促進剤
CN118946277A (zh) 肠膜样明串珠菌cjlm119菌株及含有其培养物的食物发酵组合物
JP2023154540A (ja) 加齢性難聴の予防又は改善のための組成物
JP2023055389A (ja) バクテロイデス属細菌の増殖促進剤
KR100464847B1 (ko) 간장해 예방·치료효과를 갖는 클로스트리듐·부티리컴, 및 그배양물을 포함하는 간비호제, 식품 및 사료
JPWO1998036050A1 (ja) 肝障害予防・治療効果を有するクロストリジウム・ブチリカム、およびその培養物からなる肝庇護剤、食品及び飼料
JP2021182889A (ja) 肺機能改善用組成物、および肺疾患の予防、治療または症状軽減用組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230623

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230623

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230912

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231024

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231107

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231130

R150 Certificate of patent or registration of utility model

Ref document number: 7401156

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150